Mimedx Group Inc (MDXG) concluded trading on Thursday at a closing price of $9.23, with 5.28 million shares of worth about $48.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.98% during that period and on November 14, 2024 the price saw a gain of about 23.56%. Currently the company’s common shares owned by public are about 146.23M shares, out of which, 114.71M shares are available for trading.
Stock saw a price change of 24.06% in past 5 days and over the past one month there was a price change of 57.78%. Year-to-date (YTD), MDXG shares are showing a performance of 5.25% which increased to 37.97% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.47 but also hit the highest price of $9.27 during that period. The average intraday trading volume for Mimedx Group Inc shares is 597.53K. The stock is currently trading 37.50% above its 20-day simple moving average (SMA20), while that difference is up 47.90% for SMA50 and it goes to 32.20% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mimedx Group Inc (NASDAQ: MDXG) currently have 146.23M outstanding shares and institutions hold larger chunk of about 48.13% of that.
The stock has a current market capitalization of $1.36B and its 3Y-monthly beta is at 1.91. PE ratio of stock for trailing 12 months is 15.77, while it has posted earnings per share of $0.59 in the same period. Its PEG reads 1.05 and has Quick Ratio of 3.53 while making debt-to-equity ratio of 0.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MDXG, volatility over the week remained 6.40% while standing at 4.82% over the month.
Stock’s fiscal year EPS is expected to drop by -19.46% while it is estimated to increase by 4.03% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on July 02, 2024 offering an Overweight rating for the stock and assigned a target price of $11 to it. Coverage by Lake Street stated Mimedx Group Inc (MDXG) stock as a Buy in their note to investors on March 07, 2024, suggesting a price target of $12 for the stock. On October 27, 2023, Craig Hallum Initiated their recommendations, while on October 13, 2022, Mizuho Initiated their ratings for the stock with a price target of $7. Stock get an Outperform rating from Northland Capital on July 26, 2021.
